A Prospective, Registry-based, Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant: The Migraine Observational Nurtec Pregnancy Registry (MONITOR)

26/01/2022
26/11/2025
EU PAS number:
EUPAS45356
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C4951005_MONITOR PROTOCOL CLEAN_V1.0_18AUG2021.pdf

English (581.92 KB - PDF) View document
Updated protocol

C4951005_MONITOR PROTOCOL CLEAN_V7.0_11AUG2025.pdf

First published: 14/11/2025
English (729.83 KB - PDF) View document

C4951005_MONITOR PROTOCOL CLEAN_V6.0_05FEB2025.pdf

First published: 04/09/2025
English (703.44 KB - PDF) View document

C4951005_MONITOR PROTOCOL CLEAN_V2.0_08NOV2022.pdf

First published: 08/07/2025
English (745.02 KB - PDF) View document

C4951005_MONITOR PROTOCOL CLEAN_V3.0_25APR2023.pdf

First published: 30/06/2025
English (1.3 MB - PDF) View document

C4951005_MONITOR PROTOCOL CLEAN_V4.0_27FEB2024.pdf

First published: 25/06/2025
English (716.9 KB - PDF) View document

C4951005_MONITOR PROTOCOL CLEAN_V5.0_18OCT2024.pdf

First published: 13/06/2025
English (688.86 KB - PDF) View document
Study results
Study report
Other information